Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and Inhibitors.

Found throughout biology, polyvalent interactions are characterized by the simultaneous binding of multiple ligands on one biological entity to multiple receptors on another (top part of the illustration) and have a number of characteristics that monovalent interactions do not (bottom). In particular, polyvalent interactions can be collectively much stronger than corresponding monovalent interactions, and they can provide the basis for mechanisms of both agonizing and antagonizing biological interactions that are fundamentally different from those available in monovalent systems.

[1]  Chi‐Huey Wong,et al.  A Lysoganglioside/Poly-L-glutamic Acid Conjugate as a Picomolar Inhibitor of Influenza Hemagglutinin. , 1998, Angewandte Chemie.

[2]  A. Romanowska,et al.  Synthesis and Antigenic Properties of Sialic Acid Based Dendrimers. , 1995 .

[3]  Y. C. Lee,et al.  Neoglycoconjugates : preparation and applications , 1994 .

[4]  AC Tose.  Cell , 1993, Cell.

[5]  Fulvio Mavilio,et al.  Gene therapy , 1993, Nature.

[6]  F. Balkwill,et al.  The cytokine network. , 1989, Immunology today.

[7]  P. Sperryn,et al.  Blood. , 1989, British journal of sports medicine.

[8]  R. Dwek,et al.  Glycobiology , 2018, Biochimie.

[9]  K. A. Connors,et al.  Binding Constants: The Measurement of Molecular Complex Stability , 1987 .

[10]  R. Buckley.  Immunodeficiency. , 1991, Current opinion in immunology.

[11]  G. Thorbecke,et al.  IMMUNOCHEMISTRY , 1945, Annual review of biochemistry.

[12]  F. Young.  Biochemistry , 1955, The Indian Medical Gazette.

[13]  V. Georgiev.  Virology , 1955, Nature.